OIS@ASCRS 2017

Making Myopia Great Again

By Mario Admin | July 18, 2017

Gil Kliman, MD, managing director of InterWest and OIS co-chair, is joined by Stephen Slade, MD, of Slade & Baker Vision, to lead a spirited…

Read More
Masters of the Industry

A Round of Uncomfortable Questions for the Masters of the Industry

By Mario Admin | July 6, 2017

Moderator and OIS Co-Chair Bill Link asks what’s on everyone’s mind during the Masters of the Industry panel at OIS@ASCRS.

Read More
Private-Funding-Overview

SVB’s Norris Delivers Medtech Update

By Mario Admin | June 13, 2017

Jonathan Norris, managing director, Silicon Valley Bank, compares Medtech financing to biopharma start-ups. The data on deals are interesting, showing distinct trends for both sectors.…

Read More
Public-Markets-Overview

Piper Jaffray’s Gitkin Sees Interesting Times Ahead

By Mario Admin | June 13, 2017

Andrew Gitkin, head, West Coast biotechnology investment banking, Piper Jaffray, reviews the impact the Trump presidency is having on the public markets. He also hits…

Read More

B&L’s Hess Sees Huge Role for Retina in Future Growth

By Mario Admin | June 13, 2017

Chuck Hess, vice president and general manager, US Surgical, Bausch & Lomb, says retina will play a significant role in the company’s growth going forward.…

Read More

MEC President Wilde Says Waud “Tremendously Valuable”

By Mario Admin | June 13, 2017

Brent Wilde, president, Minnesota Eye Consultants, shares the biggest challenges facing ophthalmology practices. He also discusses how eye care practices are handling consolidation in comparison…

Read More
Oculeve-COO-Says-Start-up-Experience-“Addictive”-

Oculeve COO Says Start-up Experience “Addictive”

By Mario Admin | June 13, 2017

Andy Doraiswamy, former COO of Oculeve, explains how he came to play a key role in the development of Oculeve, the dry eye company acquired…

Read More
Piper-Jaffray’sGitkin-Sees-Upticks-in-M&A-IPOs

Piper Jaffray’s Gitkin Sees Upticks in M&A/IPOs

By Mario Admin | June 13, 2017

Andrew Gitkin, head of West Coast biotechnology investment banking – Piper Jaffray, says ophthalmology start-ups stand to benefit from a “renaissance of information” that’s giving…

Read More
NEA’s-Behbahani-Discusses-VCs’-Interest-in-Ophthalmology

NEA’s Behbahani Discusses VCs’ Interest in Ophthalmology

By Mario Admin | June 13, 2017

Ali Behbahani, MD, partner at NEA, outlines the “unique aspects” that make ophthalmology an interesting area for VCs to invest capital. He also explains what…

Read More
Lindstrom-Speaks-to-Opportunities-and-Questions-Brought-by-Private-Equity-Investors

Lindstrom Speaks to Opportunities and Questions Brought by Private Equity Investors

By Mario Admin | June 13, 2017

Richard Lindstrom, MD, founder of Minnesota Eye Consultants, discusses his group’s partnership with Waud Capital to create a new national ophthalmology practice leader. Dr. Lindstrom…

Read More
plains-Why-Private-Equity-Investors-See-Opportunity-in-Eye-Care

Varsity’s Alpern Explains Why Private Equity Investors See Opportunity in Eye Care

By Mario Admin | June 13, 2017

David Alpern, founding partner of Varsity Healthcare Partners, says the ophthalmology industry is due to run up against several financial and demographic challenges going forward.…

Read More
Glaucoma-Leader-Lewis-Says-MIGS-Has-Changed-Everything,-But-Much-More-to-Do

Glaucoma Leader Lewis Says MIGS Has Changed Everything, But Much More to Do

By Mario Admin | June 7, 2017

Richard Lewis, MD, founder of Sacramento Eye Consultants, says the arrival of MIGS has completely changed how physicians can treat glaucoma. In this interview, Lewis…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.